HB4065 - 104th General Assembly (2025-2026)
340B GRANTEE CONTRACT ACCESS
Last Action
3/27/2026 - House: Rule 19(a) / Re-referred to Rules Committee
Statutes Amended In Order of Appearance
Synopsis As Introduced
Creates the 340B Grantee Contract Pharmacy Access Act. Provides that no person, including a pharmaceutical manufacturer, may deny, restrict, or otherwise limit the acquisition of a 340B drug by a 340B grantee or a 340B contract pharmacy authorized to receive 340B drugs on behalf of the 340B grantee unless the acquisition is prohibited by federal law. Provides that the Department of Financial and Professional Regulation is authorized to enforce the Act and investigate possible violations of the Act by any person, including a pharmaceutical manufacturer. Sets forth provisions concerning preemption. Effective immediately.
Actions
| Date | Chamber | Action |
|---|---|---|
| 5/22/2025 | House | Filed with the Clerk by Rep. Rita Mayfield |
| 5/22/2025 | House | First Reading |
| 5/22/2025 | House | Referred to Rules Committee |
| 5/23/2025 | House | Added Co-Sponsor Rep. Harry Benton |
| 5/23/2025 | House | Removed Co-Sponsor Rep. Harry Benton |
| 5/23/2025 | House | Added Chief Co-Sponsor Rep. Harry Benton |
| 5/27/2025 | House | Added Chief Co-Sponsor Rep. Debbie Meyers-Martin |
| 5/27/2025 | House | Added Co-Sponsor Rep. Thaddeus Jones |
| 5/27/2025 | House | Added Co-Sponsor Rep. Lisa Davis |
| 2/11/2026 | House | Assigned to Executive Committee |
| 3/17/2026 | House | House Committee Amendment No. 1 Filed with Clerk by Rep. Rita Mayfield |
| 3/17/2026 | House | House Committee Amendment No. 1 Referred to Rules Committee |
| 3/18/2026 | House | House Committee Amendment No. 1 Rules Refers to Executive Committee |
| 3/27/2026 | House | Rule 19(a) / Re-referred to Rules Committee |
| 3/27/2026 | House | House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee |